<DOC>
	<DOC>NCT00585156</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of Celebrex on bone growth into porous coated implants, following postoperative total knee arthroplasty administration of Celebrex for pain relief.</brief_summary>
	<brief_title>The Effects of Celecoxib on Bone Ingrowth</brief_title>
	<detailed_description />
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Male VA bilateral TKA patients 18 years or older with primary OA diagnosis Patients with osteoporosis, hypersensitivity to Celebrex, allergy to tetracycline, Sulfonamides, patient with asthma, urticaria, or allergictype reactions to aspirin or NSAIDs. Patients who have had CABG. Patients with a history of peptic ulcer disease, duodenal ulcers. Female patients and patients diagnosed with unstable hypertension or hypotensive, with serum creative levels above 1.82.0 or diagnosed with severe renal disease.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>95 Years</maximum_age>
	<verification_date>March 2016</verification_date>
	<keyword>Celebrex, Bone Ingrowth, Pain relief</keyword>
</DOC>